Basepath Health
AI-native operating platform for advanced (cell and gene) therapies, providing intelligent clinical, operational, and financial workflows for health systems delivering complex pediatric treatments.
What They Do
Basepath Health sells software and care-enablement services for health systems delivering cell and gene therapies. The company positions its product around intelligent clinical, operational, and financial workflows plus longitudinal patient navigation, with an emphasis on helping providers scale access to complex therapies while supporting value-aligned arrangements with manufacturers and payers. It is an infrastructure/SaaS vendor, not a care-delivery company.
Competitive Position
Basepath operates in the infrastructure layer around advanced-therapy delivery rather than drug development itself. Its comparison set is workflow, navigation, and care-coordination vendors serving specialty and rare-disease programs, but its differentiation is a tighter focus on cell and gene therapy operations, where provider capacity, reimbursement complexity, and manufacturer coordination can all become bottlenecks.
Funding Rounds
No funding rounds on record for this company.